Ascendis Pharma A (ASND) Assets (2012 - 2026)
Ascendis Pharma A (ASND) posted Assets of $2.3 billion for Q1 2026, up 54.68% sequentially from $1.5 billion in Q4 2025, and up 110.06% YoY from $1.1 billion in Q1 2025.
Ascendis Pharma A (ASND) Assets (2012 - 2026) Analysis & Trends
Ascendis Pharma A has reported Assets for 15 years, with the latest figure at $2.3 billion in Q1 2026.
- Quarterly Assets rose 110.06% year-over-year to $2.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 billion (up 110.06% YoY) and the FY2025 annual result came in at $1.5 billion, down 54.89% from the prior year.
- Assets rose to $2.3 billion in Q1 2026 per ASND's latest filing, from $1.5 billion in the prior quarter.
- Over five years, Assets peaked at $3.4 billion in Q4 2024 and troughed at $816.6 million in Q2 2024.
- A 5-year average of $1.3 billion and a median of $1.2 billion in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2024 and 2025: Assets soared 278.36% in 2024, then plunged 54.89% in 2025.
- Over 5 years, Assets stood at $1.1 billion in 2022, then slipped by 20.1% to $888.3 million in 2023, then jumped by 278.36% to $3.4 billion in 2024, then slumped by 54.89% to $1.5 billion in 2025, then jumped by 54.68% to $2.3 billion in 2026.
- According to Business Quant data, Assets over the past three periods registered $2.3 billion, $1.5 billion, and $1.3 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.03 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.32 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 9.18 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 15.59 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 19.82 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 5.56 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 2.10 Bn |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | 2.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.35 Bn |
| Dec 31, 2025 | 1.52 Bn |
| Sep 30, 2025 | 1.35 Bn |
| Jun 30, 2025 | 1.23 Bn |
| Mar 31, 2025 | 1.12 Bn |
| Dec 31, 2024 | 3.36 Bn |
| Sep 30, 2024 | 1.20 Bn |
| Jun 30, 2024 | 816.60 Mn |
| Mar 31, 2024 | 871.81 Mn |
| Dec 31, 2023 | 888.28 Mn |
| Sep 30, 2023 | 950.57 Mn |
| Jun 30, 2023 | 897.08 Mn |
| Mar 31, 2023 | 1.04 Bn |
| Dec 31, 2022 | 1.11 Bn |
| Sep 30, 2022 | 1.28 Bn |
| Jun 30, 2022 | 1.42 Bn |
| Mar 31, 2022 | 1.55 Bn |
| Dec 31, 2021 | 2.29 Bn |
| Sep 30, 2021 | 1.42 Bn |
| Jun 30, 2021 | 1.03 Bn |